If you're using iTunes, you can subscribe to our This Month in HIV podcast feed by clicking the button below:

If you're using another podcast subscription program, copy and paste the following URL:

If you'd like to get e-mail notifications when a new podcast is posted, enter your name below:

If you have no idea what we're talking about, but would like to learn how to subscribe to a podcast, download a podcast subscription program like iTunes or Juice and follow the program's instructions. (iTunes' instructions are here; Juice's are here.)

An author named Guy Hart-Davis also wrote a book that provides instructions on how to load podcasts onto your iPod or iPod Mini using Windows or a Mac.

On Nov. 10, Egrifta (tesamorelin) became the first drug approved in the U.S. to treat unusual fat gain, or lipohypertrophy, in people with HIV. In our latest episode of This Month in HIV, we talk with noted HIV researcher Daniel Berger, M.D., about how Egrifta works, who should take it, and what else we know to date about the treatment of lipohypertrophy.